Concepedia

Characterization and quantitative determination of henagliflozin metabolites in humans

Zhendong Chen, Liang Li, Yan Zhan, Yifan Zhang, Haiyan Liu, Jianjun Zou, Dafang Zhong

Journal of Pharmaceutical and Biomedical Analysis · 2020 · 16 citations · 7 references

DOI

Concepts

References

7

SGLT-2 Inhibitors: A New Mechanism for Glycemic Control

Edward C. Chao · Clinical Diabetes · 2014 · 197 citations · Full text

, , +17

Pharmacokinetics, Metabolism, and Excretion of the Antidiabetic Agent Ertugliflozin (PF-04971729) in Healthy Male Subjects

Zhuang Miao, Gianluca Nucci, Neeta B. Amin et al. · Drug Metabolism and Disposition · 2012 · 119 citations

, , +15

Effects of Renal Impairment on the Pharmacokinetics of Morinidazole: Uptake Transporter-Mediated Renal Clearance of the Conjugated Metabolites

Kan Zhong, Xiuli Li, Cen Xie et al. · Antimicrobial Agents and Chemotherapy · 2014 · 29 citations · Full text

, , +16

Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus

Xiaolan Yong, Aidong Wen, Xiangyang Liu et al. · Clinical Drug Investigation · 2015 · 20 citations

, , +16

Increased Plasma Exposures of Conjugated Metabolites of Morinidazole in Renal Failure Patients: A Critical Role of Uremic Toxins

Fandi Kong, Xiaoyan Pang, Kan Zhong et al. · Drug Metabolism and Disposition · 2017 · 17 citations

, , +17